Go Pro
→ The Starlink of Energy (From Monument Traders Alliance) (Ad)tc pixel Free PYPD Stock Alerts

PolyPid (PYPD) News Today

PolyPid logo
$4.24 +0.24 (+6.00%)
Closing price 07/23/2026 04:00 PM Eastern
Extended Trading
$4.26 +0.02 (+0.59%)
As of 07/23/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Why Is PolyPid Up Today?

PolyPid Ltd. (NASDAQ: PYPD) is trading higher after a wave of analyst commentary that was generally supportive, even though some longer-term earnings estimates were trimmed.

  • Positive Sentiment: HC Wainwright reaffirmed its Buy rating and $13.00 price target on PolyPid, which can help reinforce investor confidence in the stock’s upside potential.
  • Positive Sentiment: The firm also raised near-term Q2 2026 EPS estimates and slightly improved its Q4 2026 EPS forecast, signaling modestly better expectations for execution in the coming quarters.
  • Neutral Sentiment: HC Wainwright’s broader note updated multiple forward estimates across FY2026-FY2030, keeping attention on PolyPid’s long-term path to profitability. Article Title
  • Negative Sentiment: Some longer-dated earnings forecasts were cut, including FY2027, FY2028, FY2029, and FY2030 EPS estimates, which suggests analysts still see a bumpy road to sustained earnings growth. Article Title

Overall, PolyPid appears to be benefiting from continued analyst support and a positive stance on the stock, though some reduced long-term forecasts may temper enthusiasm. The latest news flow is broadly constructive for PYPD.

Posted 5h agoAI Generated. May Contain Errors.

PYPD Latest News

HC Wainwright Has Optimistic Outlook of PolyPid Q2 Earnings
July 23 at 6:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-has-optimistic-outlook-of-polypid-q2-earnings-2026-07-23/
HC Wainwright Reaffirms Buy Rating for PolyPid (NASDAQ:PYPD)
July 23 at 2:03 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30915535
PolyPid Ltd. (NASDAQ:PYPD) Receives Consensus Recommendation of "Moderate Buy" from Analysts
July 22 at 2:46 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30913758
PolyPid Ltd. (NASDAQ:PYPD) Receives Consensus Rating of "Moderate Buy" from Analysts
July 22 at 2:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/polypid-ltd-nasdaqpypd-receives-consensus-rating-of-moderate-buy-from-analysts-2026-07-22/
PolyPid Ltd.: PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX100 in the U.S. and Canada
July 21 at 12:56 PM  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69082111-polypid-ltd-polypid-announces-exclusive-partnership-with-azurity-pharmaceuticals-for-the-commercialization-of-d-plex100-in-the-u-s-and-canada-399.htm
PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential
July 21 at 12:56 PM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/currencies/polypid-locks-in-a-transformative-deal-worth-over-320-million-with-additional-major-royalty-potential-1036345935
PolyPid's (PYPD) "Buy" Rating Reaffirmed at HC Wainwright
July 21 at 12:11 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/polypids-pypd-buy-rating-reaffirmed-at-hc-wainwright-2026-07-21/
PolyPid, Azurity sign surgical site infection drug deal
July 21 at 7:31 AM  |  reuters.comhttps://www.reuters.com/world/polypid-azurity-sign-surgical-site-infection-drug-deal-2026-07-21/
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
July 21 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330329/0/en/polypid-announces-exclusive-partnership-with-azurity-pharmaceuticals-for-the-commercialization-of-d-plex-in-the-u-s-and-canada.html
Short Interest in PolyPid Ltd. (NASDAQ:PYPD) Drops By 42.3%
July 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/short-interest-in-polypid-ltd-nasdaqpypd-drops-by-423-2026-07-16/
AIGH Capital Management LLC Buys 250,615 Shares of PolyPid Ltd. $PYPD
July 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-aigh-capital-management-llc-buys-250615-shares-of-polypid-ltd-pypd-2026-07-09/
Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight
June 27, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PYPD/pressreleases/3005482/lillys-780m-bet-is-reshaping-surgical-infection-prevention-and-polypids-asset-is-hiding-in-plain-sight/
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
June 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/01/3304355/0/en/polypid-completes-new-drug-application-submission-to-fda-for-d-plex.html
PolyPid Stock Short Interest Report | NASDAQ:PYPD | Benzinga
May 22, 2026  |  benzinga.comhttps://www.benzinga.com/quote/PYPD/short-interest
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
May 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/20/3298464/0/en/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference.html
PolyPid’s Earnings Call Signals Tightrope to Approval
May 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypids-earnings-call-signals-tightrope-to-approval?utm_source=marketbeat.com&utm_medium=referral
PolyPid Earnings Call: NDA Momentum Amid Cash Strain
May 13, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-earnings-call-nda-momentum-amid-cash-strain?utm_source=marketbeat.com&utm_medium=referral
PolyPid (PYPD) Q1 2026 Earnings Transcript
May 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-pypd-q1-2026-earnings-190143315.html?fr=sycsrp_catchall
PolyPid Ltd (PYPD) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
May 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/polypid-ltd-pypd-q1-2026-230113482.html
PolyPid Q1 2026 Earnings Call: Complete Transcript
May 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-q1-2026-earnings-call-132439720.html
PolyPid Ltd. (PYPD) Q1 2026 Earnings Call Transcript
May 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4903973-polypid-ltd-pypd-q1-2026-earnings-call-transcript
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3293895/0/en/polypid-provides-corporate-update-and-reports-first-quarter-2026-financial-results.html
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
May 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/06/3288762/0/en/polypid-to-report-first-quarter-2026-financial-results-and-operational-highlights-on-may-13-2026.html
PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting
April 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/28/3282664/0/en/polypid-to-present-data-from-shield-ii-phase-3-trial-demonstrating-reduced-severity-of-surgical-site-infection-at-surgical-infection-society-2026-annual-meeting.html
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
April 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/13/3272567/0/en/polypid-to-present-new-phase-3-shield-ii-data-demonstrating-d-plex-sustained-local-release-at-escmid-global-2026.html
PolyPid Ltd.
April 7, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/PYPD
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
April 1, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/APLS-Q/pressreleases/1092836/polypids-moment-is-here-nda-submission-begins-as-a-high-impact-catalyst-stack-takes-shape-nasdaq-pypd/
PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA
March 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/31/3265508/0/en/polypid-initiates-d-plex-nda-submission-to-the-fda.html
Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Axsome Therapeutics (AXSM)
March 20, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/AXSM/pressreleases/852070/analysts-are-bullish-on-top-healthcare-stocks-polypid-pypd-axsome-therapeutics-axsm/
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
March 20, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OVID/pressreleases/842725/polypid-approaches-nda-submission-as-new-medicare-model-creates-strong-incentives-for-ssi-prevention/
PolyPid Ltd.: PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX100's New Drug Application
March 17, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-03/67963911-polypid-ltd-polypid-receives-pdufa-fee-waiver-from-fda-for-d-plex100-s-new-drug-application-399.htm
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX100's New Drug Application
March 17, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/03/17/10349166.htm
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
March 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-receives-pdufa-fee-waiver-123000880.html
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀'s New Drug Application
March 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/17/3257177/0/en/polypid-receives-pdufa-fee-waiver-from-fda-for-d-plex-s-new-drug-application.html
PolyPid Announces Participation in Upcoming Investor Conferences
February 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/25/3244614/0/en/polypid-announces-participation-in-upcoming-investor-conferences.html
PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 earnings call transcript
February 12, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/polypid-ltd-nasdaqpypd-q4-2025-earnings-call-transcript/ar-AA1Wdo6Y
PolyPid Earnings Call Flags Big 2026 Catalyst
February 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-earnings-call-flags-big-2026-catalyst?utm_source=marketbeat.com&utm_medium=referral
PolyPid Ltd (PYPD) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges
February 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-ltd-pypd-q4-2025-210320091.html
PolyPid (PYPD) Q4 2025 Earnings Call Transcript
February 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-pypd-q4-2025-earnings-184953651.html
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
February 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/11/3236172/0/en/polypid-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2025-financial-results.html
Preview: PolyPid's Earnings
February 11, 2026  |  benzinga.comhttps://www.benzinga.com/insights/earnings/26/02/50523815/preview-polypids-earnings
PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026
January 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/28/3227536/0/en/polypid-to-report-fourth-quarter-2025-financial-results-and-operational-highlights-on-february-11-2026.html
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation
December 31, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-calls-february-2026-extraordinary-meeting-to-approve-board-chair-compensation?utm_source=marketbeat.com&utm_medium=referral
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
December 16, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/16/3206217/0/en/polypid-appoints-veteran-medtech-leader-brooke-story-as-chairman-of-the-board-of-directors.html
PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript
December 10, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4852259-polypid-ltd-pypd-discusses-the-science-and-business-case-for-d-plex100-in-tackling-surgical
Craig-Hallum Sticks to Their Buy Rating for PolyPid (PYPD)
December 8, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PYPD/pressreleases/36490699/craig-hallum-sticks-to-their-buy-rating-for-polypid-pypd/
Roth MKM Keeps Their Buy Rating on PolyPid (PYPD)
December 5, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PYPD/pressreleases/36473985/roth-mkm-keeps-their-buy-rating-on-polypid-pypd/
PolyPid stock rises after FDA supports NDA submission for D-PLEX100
December 3, 2025  |  za.investing.comhttps://za.investing.com/news/stock-market-news/polypid-stock-rises-after-fda-supports-nda-submission-for-dplex100-93CH-4011431
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission
December 3, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/03/3198886/0/en/polypid-announces-positive-fda-pre-nda-meeting-minutes-for-d-plex-supporting-nda-submission.html
PolyPid Expands Share Offering to Strengthen Financial Position
November 26, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-expands-share-offering-to-strengthen-financial-position?utm_source=marketbeat.com&utm_medium=referral
Get PolyPid News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PYPD Media Mentions By Week

PYPD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PYPD
News Sentiment
▼
0.26

0.66
▲
Average
Medical
News Sentiment

PYPD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PYPD Articles
This Week
▼
18

3
▲
PYPD Articles
Average Week

Get the Latest News and Ratings for PYPD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for PolyPid and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:PYPD) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Elon's next move will be bigger than the IPO – and it could happen any day now
Hedge fund legend Larry Benedict - who delivered a 279% return on cash in 2025 and went on a 20-year winning s...
Brownstone Research | Sponsoredtc pixel
The SpaceX IPO Wasn't For You
Just one mile from SpaceX's launchpad sits a small company doing something SpaceX can't - and it still trades ...
Freedom Financial | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
The $40 billion "side project" Elon buried inside SpaceX
Elon Musk has been quietly building a $40 billion project inside SpaceX — housed in a converted refrigerator f...
The Oxford Club | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
Gates. Google. The Pentagon.
Bill Gates wrote a $100 million check. Google signed a 15-year contract. The Pentagon named it their top energ...
Behind the Markets | Sponsoredtc pixel